Health Trials

Recurrent or Progressive Glioblastoma

1

Review clinical trials related to Recurrent or Progressive Glioblastoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients

Clinical study evaluating the safety and efficacy of WL276 CAR-T cell therapy in CD276 positive recurrent or progressive glioblastoma patients

Participants needed: 6
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Beijing Immunochina Medical Science & Technology Co., Ltd.Updated: Nov 18, 2024
Eligibility criteria

Diagnosed with glioblastoma through histopathological examination; [+8]

Those who require the use of immunosuppressants; Or individuals with autoimmune... [+19]

Read more